These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1498517)

  • 21. Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study.
    Vicart S; Franques J; Bouhour F; Magot A; Péréon Y; Sacconi S; Nadaj-Pakleza A; Behin A; Zahr N; Hézode M; Fournier E; Payan C; Lacomblez L; Fontaine B
    Neuromuscul Disord; 2021 Nov; 31(11):1124-1135. PubMed ID: 34702654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The differential diagnosis of myotonic syndromes: A case report-guided and neurophysiologic approach.
    Cirillo G; Todisco V; Tedeschi G
    J Neurol Sci; 2016 Jan; 360():98-9. PubMed ID: 26723982
    [No Abstract]   [Full Text] [Related]  

  • 23. Respiratory muscle dysfunction in myotonia congenita.
    Estenne M; Borenstein S; De Troyer A
    Am Rev Respir Dis; 1984 Oct; 130(4):681-4. PubMed ID: 6486563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel CLCN1 mutation: P480T in a Japanese family with Thomsen's myotonia congenita.
    Sasaki R; Ito N; Shimamura M; Murakami T; Kuzuhara S; Uchino M; Uyama E
    Muscle Nerve; 2001 Mar; 24(3):357-63. PubMed ID: 11353420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translational approach to address therapy in myotonia permanens due to a new SCN4A mutation.
    Desaphy JF; Carbonara R; D'Amico A; Modoni A; Roussel J; Imbrici P; Pagliarani S; Lucchiari S; Lo Monaco M; Conte Camerino D
    Neurology; 2016 May; 86(22):2100-8. PubMed ID: 27164696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond the muscular involvement in non-dystrophic myotonias: The emerging role of neuromodulation.
    Portaro S; Naro A; Bramanti A; Leo A; Manuli A; Balletta T; Trinchera A; Bramanti P; Calabrò RS
    Restor Neurol Neurosci; 2018; 36(4):459-467. PubMed ID: 29889082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thomsen's myotonia congenita. (Clinical study of 4 cases)].
    Castello MA; Tucciarone L; Lendvai D
    Policlinico Prat; 1969 Oct; 76(43):1377-82. PubMed ID: 5402142
    [No Abstract]   [Full Text] [Related]  

  • 28. [Nosological similarity of Thomsen's myotonia and myotonia atrophica].
    Lobzin VS; Buzinovskiĭ IS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(7):976-8. PubMed ID: 5077769
    [No Abstract]   [Full Text] [Related]  

  • 29. Myotonia congenita (Thomsen's disease) excluded from the region of the myotonic dystrophy locus on chromosome 19.
    Koch M; Harley H; Sarfarazi M; Bender K; Wienker T; Zoll B; Harper PS
    Hum Genet; 1989 May; 82(2):163-6. PubMed ID: 2722193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effective treatment of paramyotonia congenita by mexiletene].
    Nezu A; Yamashita S; Miyake S; Hayashi M; Iwamoto H
    No To Hattatsu; 1986 May; 18(3):236-7. PubMed ID: 3707771
    [No Abstract]   [Full Text] [Related]  

  • 31. Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs.
    Desaphy JF; Carbonara R; Costanza T; Conte Camerino D
    Exp Neurol; 2014 May; 255(100):96-102. PubMed ID: 24613829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of dystrophia myotonica (myotonic dystrophy) and myotonia congenita (Thomsen's disease).
    CAUGHEY JE
    Neurology; 1958 Jun; 8(6):469-76. PubMed ID: 13566386
    [No Abstract]   [Full Text] [Related]  

  • 33. [Results of electromyographical and mechanographical investigations in myotonia congenita (author's transl)].
    Wagner A; Zett L
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1982 Mar; 13(1):14-21. PubMed ID: 6806065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Contribution to the clinical and genetic study of dystrophia myotonica (Steinert) and of myotonia congenita (Thomsen). Description of 8 families afflicted with Steinert's disease and of a recent case of Thomsen's disease].
    DUMAINE L; LOZERON P
    J Genet Hum; 1961 Dec; 10():221-96. PubMed ID: 13888352
    [No Abstract]   [Full Text] [Related]  

  • 35. Co-occurrence of multiple sclerosis and Thomsen's myotonia: a report of two cases.
    Ashtari F; Bahreini SA; Zahednasab H
    Funct Neurol; 2014; 29(4):269-71. PubMed ID: 25764257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of paramyotonia congenita with acetazolamide.
    Benstead TJ; Camfield PR; King DB
    Can J Neurol Sci; 1987 May; 14(2):156-8. PubMed ID: 3607618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Steinert's myotonic dystrophy and Thomsen's congenital myotonia. Observation of a family (author's transl)].
    Cognazzo A; Grasso E; Gerbino Promis PC
    Riv Patol Nerv Ment; 1979; 100(4):209-19. PubMed ID: 555540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrical myotonia in heterozygous carriers of recessive myotonia congenita.
    Deymeer F; Lehmann-Horn F; Serdaroğlu P; Cakirkaya S; Benz S; Rüdel R; Ozdemir C
    Muscle Nerve; 1999 Jan; 22(1):123-5. PubMed ID: 9883868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium channel slow inactivation as a therapeutic target for myotonia congenita.
    Novak KR; Norman J; Mitchell JR; Pinter MJ; Rich MM
    Ann Neurol; 2015 Feb; 77(2):320-32. PubMed ID: 25515836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single fiber EMG and spectral analysis of surface EMG in myotonia congenita with or without transient weakness.
    Lagueny A; Marthan R; Schuermans P; Le Collen P; Ferrer X; Julien J
    Muscle Nerve; 1994 Feb; 17(2):248-50. PubMed ID: 8114798
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.